The impact of discontinuation of aspirin within 24 months among the high risk patients who are receiving prolonged dual antiplatelet therapy after implantation of second-generation drug-eluting stents

29 August 2020 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Pharmacology and Pharmacotherapy ePosters Antiplatelet Drugs ESC Premium Access ESC Congress 2020

ESC 365 is supported by

ESC 365 is supported by